#BIOSPAIN2025 | “Abioinnova has decided to support BIOSPAIN 2025, the leading meeting of the biotechnology sector in Europe”
We interviewed Pedro Martínez Córdoba, Councillor for Economic Promotion of Salamanca City Council, Gold Sponsor of BIOSPAIN 2025, to analyze the Abioinnova initiative.
Within the framework of BIOSPAIN 2025, one of the most important biotechnology events in Europe, Salamanca positions itself as a benchmark thanks to Abioinnova, the biosanitary innovation center promoted by the City Council. As a Gold Sponsor of this international meeting, Abioinnova strengthens its commitment to biotechnology, health, and the creation of an innovation ecosystem that projects Salamanca onto the national and international stage.
On the occasion of this sponsorship, we spoke with Pedro Martínez Córdoba, Councillor for Economic Promotion of Salamanca City Council, to learn more about Abioinnova’s objectives, its role within the Salamanca Tech strategy, and the expectations behind its support for BIOSPAIN 2025.
AseBio. What is Abioinnova and what is the origin of this initiative promoted by Salamanca City Council?
Pedro Martínez Córdoba. Abioinnova is the biosanitary innovation center promoted by Salamanca City Council with the aim of consolidating the city as a national and international benchmark in biotechnology and health. It was born as a strategic commitment to foster knowledge transfer and support the creation of new companies in a high value-added sector.
AseBio. What are Abioinnova’s main strategic objectives in terms of innovation, employment, and development of the biosanitary sector in the city and its surroundings?
Pedro Martínez Córdoba. Our objectives focus on driving innovation in the biosanitary field, fostering the creation of qualified jobs, and contributing to the development of a solid business fabric that enhances the competitiveness of Salamanca and its surrounding area in the biotechnology sector.
AseBio. Where is Abioinnova’s infrastructure located and what equipment or services does it offer to biosanitary startups?
Pedro Martínez Córdoba. Abioinnova is located in Salamanca, integrated within the municipal strategy Salamanca Tech. The infrastructure includes state-of-the-art laboratories, collaborative workspaces, and specialized support services for biosanitary startups, providing an optimal environment for research, development, and innovation.
AseBio. What type of projects and areas of specialization does Abioinnova currently host?
Pedro Martínez Córdoba. It currently hosts projects in biotechnology, advanced therapies, diagnostics, personalized medicine, rare diseases, and the design of medical devices through 3D bioprinting.
AseBio. What programs or activities has Abioinnova launched to promote internationalization, financing, and the consolidation of its startups?
Pedro Martínez Córdoba. We have launched business acceleration programs, mentoring activities with international experts, initiatives to support investment attraction, and active participation in international sector forums and events, in order to promote the projection and consolidation of our startups.
AseBio. What role does Abioinnova play within the municipal strategy Salamanca Tech, and how does this initiative fit into the local technological innovation ecosystem?
Pedro Martínez Córdoba. Abioinnova is a cornerstone of the Salamanca Tech strategy, as it provides the biosanitary dimension to the initiative that drives innovation and technological development in the city. It connects Salamanca’s academic and research excellence with the business sector, positioning the city as an innovation hub.
AseBio. As Gold Sponsor at BIOSPAIN 2025, why has Abioinnova decided to support this event and what do you expect to achieve through your participation?
Pedro Martínez Córdoba. Abioinnova has decided to support BIOSPAIN 2025 as a Gold Sponsor because it is the leading meeting of the biotechnology sector in Europe and a unique showcase to highlight Salamanca’s potential. Through our participation, we aim to strengthen strategic alliances, attract investment projects, and consolidate Abioinnova’s position as a benchmark in the biosanitary field.